HEADER HYDROLASE/HYDROLASE INHIBITOR 22-JAN-14 4OKG TITLE LPXC FROM P.AERUGINOSA WITH THE INHIBITOR 6-(BENZIMIDAZOL-1-YL)-5-[4- TITLE 2 [2-[6-[(4-METHYLPIPERAZIN-1-YL)METHYL]-3- TITLE 3 PYRIDYL]ETHYNYL]PHENYL]PYRIDINE-3-CARBOHYDROXAMIC ACID COMPND MOL_ID: 1; COMPND 2 MOLECULE: UDP-3-O-[3-HYDROXYMYRISTOYL] N-ACETYLGLUCOSAMINE COMPND 3 DEACETYLASE; COMPND 4 CHAIN: A, B; COMPND 5 SYNONYM: PROTEIN ENVA, UDP-3-O-ACYL-GLCNAC DEACETYLASE; COMPND 6 EC: 3.5.1.-; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PSEUDOMONAS AERUGINOSA; SOURCE 3 ORGANISM_TAXID: 208964; SOURCE 4 STRAIN: PAO1; SOURCE 5 GENE: ENVA, LPXC, PA4406; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)DELTA-ACRB; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET-21B KEYWDS HYDROXAMATE, BETA-ALPHA-ALPHA-BETA SANDWICH, DEACETYLASE, KEYWDS 2 INTRACELLULAR; CYTOPLASM, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.B.OLIVIER,S.D.LAHIRI,D.B.PRINCE REVDAT 2 28-FEB-24 4OKG 1 REMARK SEQADV LINK REVDAT 1 24-SEP-14 4OKG 0 JRNL AUTH N.GAO,S.M.MCLEOD,H.HAJEC,S.D.LAHIRI,D.B.PRINCE,J.THRESHER, JRNL AUTH 2 J.WHITEAKER,P.ROSS,N.B.OLIVIER,P.DOIG JRNL TITL OVEREXPRESSION OF PSEUDOMONAS AERUGINOSA LPXC IN THE JRNL TITL 2 PRESENCE OF AN INHIBITOR IN AN ACRB DELETION ESCHERICHIA JRNL TITL 3 COLI STRAIN FOR STRUCTURAL STUDIES JRNL REF PROTEIN EXPRESS.PURIF. 2014 JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.06 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.06 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.55 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.3 REMARK 3 NUMBER OF REFLECTIONS : 31031 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.169 REMARK 3 R VALUE (WORKING SET) : 0.167 REMARK 3 FREE R VALUE : 0.219 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 1567 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 16 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.06 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.13 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.29 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2390 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1784 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2261 REMARK 3 BIN R VALUE (WORKING SET) : 0.1760 REMARK 3 BIN FREE R VALUE : 0.2201 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.40 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 129 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4597 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 84 REMARK 3 SOLVENT ATOMS : 377 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 23.04 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.81 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.62760 REMARK 3 B22 (A**2) : 1.08170 REMARK 3 B33 (A**2) : -1.70930 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.19360 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.203 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.239 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.944 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.916 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4765 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 6440 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1672 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 123 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 693 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4765 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : 0 ; 5.000 ; SEMIHARMONIC REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 613 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5768 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.09 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.60 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.90 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4OKG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-JAN-14. REMARK 100 THE DEPOSITION ID IS D_1000084605. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-OCT-10 REMARK 200 TEMPERATURE (KELVIN) : 140 REMARK 200 PH : 8.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : RIGAKU VARIMAX; GRADED, REMARK 200 MULTILAYER CONFOCAL OPTIC REMARK 200 OPTICS : VARI MAX HR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944+ REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31059 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.060 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 200 DATA REDUNDANCY : 2.700 REMARK 200 R MERGE (I) : 0.06400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 28.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.06 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.10 REMARK 200 COMPLETENESS FOR SHELL (%) : 81.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.00 REMARK 200 R MERGE FOR SHELL (I) : 0.10900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASES REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 39.42 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: COCRYSTALLIZATION; PROTEIN IN THE REMARK 280 FOLLOWING BUFFER: 20MM HEPES PH7.3, 150 MM NACL, 2MM DTT, 10% REMARK 280 GLYCEROL AND CONCENTRATED TO 11.3 MG/ML. WELL SOLUTION CONTAINED: REMARK 280 2.2M AMMONIUM SULFATE, 0.1 M TRIS PH 8.3, 4.1% PEG 400, 29 MM REMARK 280 NAPO4 DI-BASIC. PROTEIN COEXPRESSED WITH COMPOUND AND WELL REMARK 280 SOLUTION WERE COMBINED 1:1 AS A SITTING DROP. CRYSTALS HARVESTED REMARK 280 APPROXIMATELY 21 DAYS LATER., VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 78.55750 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP B 161 REMARK 465 HIS B 162 REMARK 465 PRO B 163 REMARK 465 VAL B 164 REMARK 465 PHE B 165 REMARK 465 ARG B 166 REMARK 465 GLY B 167 REMARK 465 ARG B 168 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 103 -125.12 59.10 REMARK 500 HIS A 162 143.61 162.57 REMARK 500 ARG A 166 -6.43 72.25 REMARK 500 ASN A 213 11.27 -140.82 REMARK 500 GLU A 219 -77.17 73.22 REMARK 500 ASP A 232 40.23 -108.97 REMARK 500 MET B 103 -124.04 59.50 REMARK 500 ASN B 204 37.27 71.31 REMARK 500 GLU B 219 -6.49 168.45 REMARK 500 ASN B 220 -54.34 -120.97 REMARK 500 ARG B 298 115.66 175.98 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 301 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS A 78 NE2 REMARK 620 2 HIS A 237 NE2 94.0 REMARK 620 3 ASP A 241 OD1 93.7 98.5 REMARK 620 4 2SZ A 302 O41 97.9 168.0 82.3 REMARK 620 5 2SZ A 302 O39 109.5 100.2 148.9 74.4 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 301 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HIS B 78 NE2 REMARK 620 2 HIS B 237 NE2 92.2 REMARK 620 3 ASP B 241 OD1 94.2 100.9 REMARK 620 4 ASP B 241 OD2 148.3 94.4 54.1 REMARK 620 5 2SZ B 302 O41 100.2 166.3 84.2 78.1 REMARK 620 6 2SZ B 302 O39 115.1 93.8 146.7 95.3 75.7 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2SZ A 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2SZ B 302 DBREF 4OKG A 1 299 UNP P47205 LPXC_PSEAE 1 299 DBREF 4OKG B 1 299 UNP P47205 LPXC_PSEAE 1 299 SEQADV 4OKG SER A 40 UNP P47205 CYS 40 ENGINEERED MUTATION SEQADV 4OKG SER B 40 UNP P47205 CYS 40 ENGINEERED MUTATION SEQRES 1 A 299 MET ILE LYS GLN ARG THR LEU LYS ASN ILE ILE ARG ALA SEQRES 2 A 299 THR GLY VAL GLY LEU HIS SER GLY GLU LYS VAL TYR LEU SEQRES 3 A 299 THR LEU LYS PRO ALA PRO VAL ASP THR GLY ILE VAL PHE SEQRES 4 A 299 SER ARG THR ASP LEU ASP PRO VAL VAL GLU ILE PRO ALA SEQRES 5 A 299 ARG ALA GLU ASN VAL GLY GLU THR THR MET SER THR THR SEQRES 6 A 299 LEU VAL LYS GLY ASP VAL LYS VAL ASP THR VAL GLU HIS SEQRES 7 A 299 LEU LEU SER ALA MET ALA GLY LEU GLY ILE ASP ASN ALA SEQRES 8 A 299 TYR VAL GLU LEU SER ALA SER GLU VAL PRO ILE MET ASP SEQRES 9 A 299 GLY SER ALA GLY PRO PHE VAL PHE LEU ILE GLN SER ALA SEQRES 10 A 299 GLY LEU GLN GLU GLN GLU ALA ALA LYS LYS PHE ILE ARG SEQRES 11 A 299 ILE LYS ARG GLU VAL SER VAL GLU GLU GLY ASP LYS ARG SEQRES 12 A 299 ALA VAL PHE VAL PRO PHE ASP GLY PHE LYS VAL SER PHE SEQRES 13 A 299 GLU ILE ASP PHE ASP HIS PRO VAL PHE ARG GLY ARG THR SEQRES 14 A 299 GLN GLN ALA SER VAL ASP PHE SER SER THR SER PHE VAL SEQRES 15 A 299 LYS GLU VAL SER ARG ALA ARG THR PHE GLY PHE MET ARG SEQRES 16 A 299 ASP ILE GLU TYR LEU ARG SER GLN ASN LEU ALA LEU GLY SEQRES 17 A 299 GLY SER VAL GLU ASN ALA ILE VAL VAL ASP GLU ASN ARG SEQRES 18 A 299 VAL LEU ASN GLU ASP GLY LEU ARG TYR GLU ASP GLU PHE SEQRES 19 A 299 VAL LYS HIS LYS ILE LEU ASP ALA ILE GLY ASP LEU TYR SEQRES 20 A 299 LEU LEU GLY ASN SER LEU ILE GLY GLU PHE ARG GLY PHE SEQRES 21 A 299 LYS SER GLY HIS ALA LEU ASN ASN GLN LEU LEU ARG THR SEQRES 22 A 299 LEU ILE ALA ASP LYS ASP ALA TRP GLU VAL VAL THR PHE SEQRES 23 A 299 GLU ASP ALA ARG THR ALA PRO ILE SER TYR MET ARG PRO SEQRES 1 B 299 MET ILE LYS GLN ARG THR LEU LYS ASN ILE ILE ARG ALA SEQRES 2 B 299 THR GLY VAL GLY LEU HIS SER GLY GLU LYS VAL TYR LEU SEQRES 3 B 299 THR LEU LYS PRO ALA PRO VAL ASP THR GLY ILE VAL PHE SEQRES 4 B 299 SER ARG THR ASP LEU ASP PRO VAL VAL GLU ILE PRO ALA SEQRES 5 B 299 ARG ALA GLU ASN VAL GLY GLU THR THR MET SER THR THR SEQRES 6 B 299 LEU VAL LYS GLY ASP VAL LYS VAL ASP THR VAL GLU HIS SEQRES 7 B 299 LEU LEU SER ALA MET ALA GLY LEU GLY ILE ASP ASN ALA SEQRES 8 B 299 TYR VAL GLU LEU SER ALA SER GLU VAL PRO ILE MET ASP SEQRES 9 B 299 GLY SER ALA GLY PRO PHE VAL PHE LEU ILE GLN SER ALA SEQRES 10 B 299 GLY LEU GLN GLU GLN GLU ALA ALA LYS LYS PHE ILE ARG SEQRES 11 B 299 ILE LYS ARG GLU VAL SER VAL GLU GLU GLY ASP LYS ARG SEQRES 12 B 299 ALA VAL PHE VAL PRO PHE ASP GLY PHE LYS VAL SER PHE SEQRES 13 B 299 GLU ILE ASP PHE ASP HIS PRO VAL PHE ARG GLY ARG THR SEQRES 14 B 299 GLN GLN ALA SER VAL ASP PHE SER SER THR SER PHE VAL SEQRES 15 B 299 LYS GLU VAL SER ARG ALA ARG THR PHE GLY PHE MET ARG SEQRES 16 B 299 ASP ILE GLU TYR LEU ARG SER GLN ASN LEU ALA LEU GLY SEQRES 17 B 299 GLY SER VAL GLU ASN ALA ILE VAL VAL ASP GLU ASN ARG SEQRES 18 B 299 VAL LEU ASN GLU ASP GLY LEU ARG TYR GLU ASP GLU PHE SEQRES 19 B 299 VAL LYS HIS LYS ILE LEU ASP ALA ILE GLY ASP LEU TYR SEQRES 20 B 299 LEU LEU GLY ASN SER LEU ILE GLY GLU PHE ARG GLY PHE SEQRES 21 B 299 LYS SER GLY HIS ALA LEU ASN ASN GLN LEU LEU ARG THR SEQRES 22 B 299 LEU ILE ALA ASP LYS ASP ALA TRP GLU VAL VAL THR PHE SEQRES 23 B 299 GLU ASP ALA ARG THR ALA PRO ILE SER TYR MET ARG PRO HET ZN A 301 1 HET 2SZ A 302 41 HET ZN B 301 1 HET 2SZ B 302 41 HETNAM ZN ZINC ION HETNAM 2SZ 6-(1H-BENZIMIDAZOL-1-YL)-N-HYDROXY-5-[4-({6-[(4- HETNAM 2 2SZ METHYLPIPERAZIN-1-YL)METHYL]PYRIDIN-3-YL}ETHYNYL) HETNAM 3 2SZ PHENYL]PYRIDINE-3-CARBOXAMIDE FORMUL 3 ZN 2(ZN 2+) FORMUL 4 2SZ 2(C32 H29 N7 O2) FORMUL 7 HOH *377(H2 O) HELIX 1 1 ARG A 53 VAL A 57 5 5 HELIX 2 2 VAL A 76 GLY A 87 1 12 HELIX 3 3 ALA A 107 GLY A 118 1 12 HELIX 4 4 SER A 180 VAL A 185 1 6 HELIX 5 5 MET A 194 GLN A 203 1 10 HELIX 6 6 ASP A 232 TYR A 247 1 16 HELIX 7 7 LEU A 248 GLY A 250 5 3 HELIX 8 8 GLY A 263 ASP A 277 1 15 HELIX 9 9 ASP A 288 ALA A 292 5 5 HELIX 10 10 ARG B 53 VAL B 57 5 5 HELIX 11 11 VAL B 76 GLY B 87 1 12 HELIX 12 12 ALA B 107 GLY B 118 1 12 HELIX 13 13 SER B 180 VAL B 185 1 6 HELIX 14 14 MET B 194 GLN B 203 1 10 HELIX 15 15 ASP B 232 TYR B 247 1 16 HELIX 16 16 LEU B 248 GLY B 250 5 3 HELIX 17 17 GLY B 263 ASP B 277 1 15 HELIX 18 18 ASP B 288 ALA B 292 5 5 SHEET 1 A 2 LYS A 3 LEU A 7 0 SHEET 2 A 2 LEU A 119 ALA A 125 -1 O GLN A 120 N THR A 6 SHEET 1 B 5 ILE A 11 VAL A 16 0 SHEET 2 B 5 LYS A 23 PRO A 30 -1 O LEU A 26 N ALA A 13 SHEET 3 B 5 ALA A 91 LEU A 95 -1 O GLU A 94 N THR A 27 SHEET 4 B 5 ILE A 37 ARG A 41 1 N SER A 40 O LEU A 95 SHEET 5 B 5 VAL A 48 PRO A 51 -1 O ILE A 50 N PHE A 39 SHEET 1 C 2 THR A 65 LYS A 68 0 SHEET 2 C 2 VAL A 71 ASP A 74 -1 O VAL A 73 N LEU A 66 SHEET 1 D 5 VAL A 135 GLU A 139 0 SHEET 2 D 5 LYS A 142 VAL A 147 -1 O PHE A 146 N VAL A 135 SHEET 3 D 5 SER A 252 PHE A 260 -1 O PHE A 260 N ARG A 143 SHEET 4 D 5 PHE A 152 VAL A 164 1 N SER A 155 O PHE A 257 SHEET 5 D 5 GLY A 167 ASP A 175 -1 O ARG A 168 N PHE A 160 SHEET 1 E 5 VAL A 135 GLU A 139 0 SHEET 2 E 5 LYS A 142 VAL A 147 -1 O PHE A 146 N VAL A 135 SHEET 3 E 5 SER A 252 PHE A 260 -1 O PHE A 260 N ARG A 143 SHEET 4 E 5 PHE A 128 ILE A 131 1 N ILE A 129 O ILE A 254 SHEET 5 E 5 TRP A 281 VAL A 284 -1 O GLU A 282 N ARG A 130 SHEET 1 F 2 PHE A 191 PHE A 193 0 SHEET 2 F 2 ILE A 215 VAL A 217 1 O ILE A 215 N GLY A 192 SHEET 1 G 2 LYS B 3 LEU B 7 0 SHEET 2 G 2 LEU B 119 ALA B 125 -1 O GLN B 122 N GLN B 4 SHEET 1 H 5 ILE B 11 VAL B 16 0 SHEET 2 H 5 LYS B 23 PRO B 30 -1 O LEU B 26 N ALA B 13 SHEET 3 H 5 ALA B 91 LEU B 95 -1 O GLU B 94 N THR B 27 SHEET 4 H 5 ILE B 37 ARG B 41 1 N SER B 40 O LEU B 95 SHEET 5 H 5 VAL B 48 PRO B 51 -1 O ILE B 50 N PHE B 39 SHEET 1 I 2 THR B 65 LYS B 68 0 SHEET 2 I 2 VAL B 71 ASP B 74 -1 O VAL B 73 N LEU B 66 SHEET 1 J 5 VAL B 135 GLU B 139 0 SHEET 2 J 5 LYS B 142 VAL B 147 -1 O PHE B 146 N VAL B 135 SHEET 3 J 5 SER B 252 PHE B 260 -1 O PHE B 260 N ARG B 143 SHEET 4 J 5 PHE B 152 GLU B 157 1 N SER B 155 O PHE B 257 SHEET 5 J 5 GLN B 171 ASP B 175 -1 O VAL B 174 N VAL B 154 SHEET 1 K 5 VAL B 135 GLU B 139 0 SHEET 2 K 5 LYS B 142 VAL B 147 -1 O PHE B 146 N VAL B 135 SHEET 3 K 5 SER B 252 PHE B 260 -1 O PHE B 260 N ARG B 143 SHEET 4 K 5 PHE B 128 ILE B 131 1 N ILE B 129 O ILE B 254 SHEET 5 K 5 TRP B 281 VAL B 284 -1 O GLU B 282 N ARG B 130 SHEET 1 L 2 PHE B 191 PHE B 193 0 SHEET 2 L 2 ILE B 215 VAL B 217 1 O ILE B 215 N GLY B 192 LINK NE2 HIS A 78 ZN ZN A 301 1555 1555 2.05 LINK NE2 HIS A 237 ZN ZN A 301 1555 1555 2.13 LINK OD1 ASP A 241 ZN ZN A 301 1555 1555 2.15 LINK ZN ZN A 301 O41 2SZ A 302 1555 1555 2.04 LINK ZN ZN A 301 O39 2SZ A 302 1555 1555 2.16 LINK NE2 HIS B 78 ZN ZN B 301 1555 1555 2.14 LINK NE2 HIS B 237 ZN ZN B 301 1555 1555 2.14 LINK OD1 ASP B 241 ZN ZN B 301 1555 1555 2.06 LINK OD2 ASP B 241 ZN ZN B 301 1555 1555 2.64 LINK ZN ZN B 301 O41 2SZ B 302 1555 1555 2.12 LINK ZN ZN B 301 O39 2SZ B 302 1555 1555 2.15 CISPEP 1 ASP A 45 PRO A 46 0 -4.87 CISPEP 2 ASP A 161 HIS A 162 0 -1.69 CISPEP 3 HIS A 162 PRO A 163 0 -8.72 CISPEP 4 ASP B 45 PRO B 46 0 -4.42 SITE 1 AC1 4 HIS A 78 HIS A 237 ASP A 241 2SZ A 302 SITE 1 AC2 18 MET A 62 GLU A 77 HIS A 78 THR A 190 SITE 2 AC2 18 PHE A 191 MET A 194 ILE A 197 ARG A 201 SITE 3 AC2 18 ALA A 206 GLY A 209 SER A 210 VAL A 216 SITE 4 AC2 18 HIS A 237 ASP A 241 HIS A 264 ZN A 301 SITE 5 AC2 18 HOH A 411 HOH A 587 SITE 1 AC3 4 HIS B 78 HIS B 237 ASP B 241 2SZ B 302 SITE 1 AC4 18 MET B 62 GLU B 77 HIS B 78 THR B 190 SITE 2 AC4 18 PHE B 191 ILE B 197 LEU B 200 ARG B 201 SITE 3 AC4 18 ALA B 206 GLY B 209 SER B 210 VAL B 216 SITE 4 AC4 18 HIS B 237 ASP B 241 HIS B 264 ZN B 301 SITE 5 AC4 18 HOH B 430 HOH B 433 CRYST1 35.770 157.115 48.946 90.00 101.87 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.027956 0.000000 0.005876 0.00000 SCALE2 0.000000 0.006365 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020877 0.00000